Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45208, USA.
Sackler Faculty of Medicine, Tel-Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel.
Crit Care. 2023 Jun 12;27(1):230. doi: 10.1186/s13054-023-04518-2.
Sepsis-induced endothelial dysfunction is proposed to cause angiotensin-converting enzyme (ACE) dysfunction and renin-angiotensin-aldosterone system (RAAS) derangement, exacerbating vasodilatory shock and acute kidney injury (AKI). Few studies test this hypothesis directly, including none in children. We measured serum ACE concentrations and activity, and assessed their association with adverse kidney outcomes in pediatric septic shock.
A pilot study of 72 subjects aged 1 week-18 years from an existing multicenter, observational study. Serum ACE concentrations and activity were measured on Day 1; renin + prorenin concentrations were available from a previous study. The associations between individual RAAS components and a composite outcome (Day 1-7 severe persistent AKI, kidney replacement therapy use, or mortality) were assessed.
50/72 subjects (69%) had undetectable ACE activity (< 2.41 U/L) on Day 1 and 27/72 (38%) developed the composite outcome. Subjects with undetectable ACE activity had higher Day 1 renin + prorenin compared to those with activity (4533 vs. 2227 pg/ml, p = 0.017); ACE concentrations were no different between groups. Children with the composite outcome more commonly had undetectable ACE activity (85% vs. 65%, p = 0.025), and had higher Day 1 renin + prorenin (16,774 pg/ml vs. 3037 pg/ml, p < 0.001) and ACE concentrations (149 vs. 96 pg/ml, p = 0.019). On multivariable regression, increasing ACE concentrations (aOR 1.01, 95%CI 1.002-1.03, p = 0.015) and undetectable ACE activity (aOR 6.6, 95%CI 1.2-36.1, p = 0.031) retained associations with the composite outcome.
ACE activity is diminished in pediatric septic shock, appears uncoupled from ACE concentrations, and is associated with adverse kidney outcomes. Further study is needed to validate these findings in larger cohorts.
据推测,脓毒症引起的血管内皮功能障碍会导致血管紧张素转换酶(ACE)功能障碍和肾素-血管紧张素-醛固酮系统(RAAS)失调,从而加重血管舒张性休克和急性肾损伤(AKI)。很少有研究直接验证这一假说,包括儿科研究。我们测量了血清 ACE 浓度和活性,并评估了它们与儿科脓毒性休克不良肾脏结局的关系。
这是一项来自现有多中心观察性研究的 72 例 1 周至 18 岁儿童的试点研究。在第 1 天测量血清 ACE 浓度和活性;肾素+前肾素浓度可从之前的研究中获得。评估单个 RAAS 成分与复合结局(第 1-7 天严重持续 AKI、肾脏替代治疗使用或死亡)之间的关系。
50/72 例(69%)受试者在第 1 天的 ACE 活性(<2.41 U/L)无法检测到,27/72 例(38%)发生了复合结局。与有活性的 ACE 相比,无活性 ACE 的第 1 天肾素+前肾素水平更高(4533 与 2227 pg/ml,p=0.017);两组间 ACE 浓度无差异。发生复合结局的患儿更常见 ACE 活性无法检测到(85% vs. 65%,p=0.025),且第 1 天肾素+前肾素(16774 pg/ml vs. 3037 pg/ml,p<0.001)和 ACE 浓度(149 vs. 96 pg/ml,p=0.019)更高。多变量回归分析显示,ACE 浓度增加(OR 1.01,95%CI 1.002-1.03,p=0.015)和 ACE 活性无法检测(OR 6.6,95%CI 1.2-36.1,p=0.031)与复合结局相关。
在儿科脓毒性休克中,ACE 活性降低,与 ACE 浓度脱耦,与不良肾脏结局相关。需要进一步的研究来验证这些发现是否在更大的队列中成立。